Empirical data, brief vignettes, clinical observations, review of clinical trial data, and the presentation of validated clinical tools provide an in-depth review of psychopharmacological treatment and assessment on a variety of topics. In addition, participants gain important advanced psychopharmacology information concerning complex psychiatric conditions, symptoms, and treatment considerations. Topics include common comorbid psychiatric disorders affecting youth with autism spectrum disorder, schizophrenia, cannabis use disorder, and comorbid conditions in the presence of attention-deficit/hyperactivity disorder (ADHD). Additional presentations look closely at aggressive behaviors, treatment of pediatric delirium, and scientific advances in ensuring medication adherence. Participants acquire information about psychopharmacology treatment considerations to apply in a variety of clinical settings.